Related Experiment Videos
[Insurance and genetics - options to prevent undesirable consequences]
1The Queen's University of Belfast, United Kingdom.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|October 19, 2001
Summary
This study explores strategies to manage genetic information risks in insurance. It assesses macro, meso, and micro-level options for their feasibility and effectiveness.
Area of Science:
- Genetics
- Insurance Law
- Bioethics
Context:
- The increasing use of molecular genetic information presents challenges for the insurance sector.
- Ethical and legal frameworks are needed to address potential genetic discrimination.
Purpose:
- To analyze various options for preventing or mitigating adverse outcomes related to genetic data in insurance.
- To categorize these options into macro, meso, and micro levels.
- To evaluate the likelihood of each option's implementation.
Summary:
- The article categorizes potential solutions for managing genetic information in insurance into three tiers: macro (societal/legislative), meso (industry-wide), and micro (individual/policy-level).
- Each category of options is assessed based on its practical feasibility and probability of adoption.
- The analysis considers the complex interplay between genetic privacy, insurance underwriting, and equitable access to coverage.
Impact:
- Provides a framework for policymakers, insurers, and genetic testing companies to navigate the ethical and practical challenges of genetic information.
- Informs the development of regulations and best practices to ensure fair treatment of individuals based on their genetic profile.
- Contributes to the ongoing discourse on genetic privacy and non-discrimination in the financial services industry.